Page last updated: 2024-08-17

apomorphine and Neuroleptic Malignant Syndrome

apomorphine has been researched along with Neuroleptic Malignant Syndrome in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (37.50)	18.2507
2000's	4 (50.00)	29.6817
2010's	1 (12.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bonanni, L; Capasso, M; Martino, G; Nasuti, M; Onofrj, M; Thomas, A	1
Onofrj, M; Thomas, A	1
Bonuccelli, U; Cassano, GB; Fagiolini, A; Lattanzi, L; Mungai, F; Romano, A	1
Esteban Muñoz, J	1
Albanese, A; Colosimo, C; Merello, M	1
Hsieh, Y; Wang, HC	1
Adachi, Y; Higuchi, H; Satoh, T; Wada, H; Watanabe, K	1
Bonuccelli, U; Corsini, GU; Muratorio, A; Piccini, P	1

Reviews

2 review(s) available for apomorphine and Neuroleptic Malignant Syndrome

Article	Year
[Apomorphine]. Neurologia (Barcelona, Spain), 1995, Volume: 10, Issue:8 Topics: Administration, Sublingual; Apomorphine; Dopamine Agonists; Humans; Injections, Subcutaneous; Movement Disorders; Neuroleptic Malignant Syndrome; Parkinson Disease	1995
Clinical usefulness of apomorphine in movement disorders. Clinical neuropharmacology, 1994, Volume: 17, Issue:3 Topics: Antiparkinson Agents; Apomorphine; Dopamine Agonists; Dystonia; Humans; Huntington Disease; Movement Disorders; Neuroleptic Malignant Syndrome; Parkinson Disease	1994

Other Studies

6 other study(ies) available for apomorphine and Neuroleptic Malignant Syndrome

Article	Year
Dopamine transporter single-photon emission computerized tomography supports diagnosis of akinetic crisis of parkinsonism and of neuroleptic malignant syndrome. Medicine, 2015, Volume: 94, Issue:13 Topics: Aged; Apomorphine; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Lewy Body Disease; Male; Neuroleptic Malignant Syndrome; Parkinson Disease; Prospective Studies; Tomography, Emission-Computed, Single-Photon	2015
Acute akinesia in Parkinson disease. Neurology, 2005, Apr-12, Volume: 64, Issue:7 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Akinetic Mutism; Apomorphine; Body Temperature; Cohort Studies; Comorbidity; Dopamine Agents; Dose-Response Relationship, Drug; Drug Resistance; Female; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Mortality; Neuroleptic Malignant Syndrome; Parkinson Disease; Prospective Studies; Recovery of Function; Treatment Failure	2005
Subcutaneous apomorphine for neuroleptic malignant syndrome. The American journal of psychiatry, 2006, Volume: 163, Issue:8 Topics: Apomorphine; Dopamine Agonists; Drug Administration Schedule; Female; Humans; Injections, Subcutaneous; Middle Aged; Neuroleptic Malignant Syndrome; Treatment Outcome	2006
Treatment of neuroleptic malignant syndrome with subcutaneous apomorphine monotherapy. Movement disorders : official journal of the Movement Disorder Society, 2001, Volume: 16, Issue:4 Topics: Adult; Apomorphine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Haloperidol; Humans; Injections, Subcutaneous; Neuroleptic Malignant Syndrome; Neurologic Examination; Schizophrenia; Trihexyphenidyl	2001
[The effect of halothane anesthesia on dopamine release induced by apomorphine or haloperidol--an in vivo microdialysis study in rats striatum]. Masui. The Japanese journal of anesthesiology, 2001, Volume: 50, Issue:10 Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Animals; Antipsychotic Agents; Apomorphine; Corpus Striatum; Dopamine; Haloperidol; Halothane; Male; Microdialysis; Neuroleptic Malignant Syndrome; Rats; Rats, Sprague-Dawley	2001
Apomorphine in malignant syndrome due to levodopa withdrawal. Italian journal of neurological sciences, 1992, Volume: 13, Issue:2 Topics: Aged; Apomorphine; Female; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome	1992